RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,011 | -25.8% | 123,337 | -39.2% | 0.00% | – |
| Q2 2023 | $498,732 | -36.6% | 202,737 | -41.7% | 0.00% | – |
| Q1 2023 | $786,196 | -53.9% | 347,874 | -28.8% | 0.00% | – |
| Q4 2022 | $1,705,699 | -84.3% | 488,739 | +67.0% | 0.00% | -100.0% |
| Q3 2022 | $10,831,000 | +80.9% | 292,610 | -7.2% | 0.00% | 0.0% |
| Q2 2022 | $5,986,000 | -16.6% | 315,237 | +18.5% | 0.00% | 0.0% |
| Q1 2022 | $7,181,000 | -44.4% | 266,065 | -53.6% | 0.00% | -50.0% |
| Q4 2021 | $12,917,000 | +9.7% | 573,321 | +27.6% | 0.00% | 0.0% |
| Q3 2021 | $11,777,000 | +1295.4% | 449,341 | +1604.7% | 0.00% | – |
| Q2 2021 | $844,000 | +1958.5% | 26,359 | +2184.1% | 0.00% | – |
| Q1 2021 | $41,000 | -89.0% | 1,154 | -90.1% | 0.00% | – |
| Q4 2020 | $373,000 | -26.3% | 11,616 | -13.6% | 0.00% | – |
| Q3 2020 | $506,000 | -75.4% | 13,444 | -70.7% | 0.00% | – |
| Q2 2020 | $2,053,000 | +7796.2% | 45,887 | +5813.3% | 0.00% | – |
| Q1 2020 | $26,000 | -90.1% | 776 | -88.5% | 0.00% | – |
| Q4 2019 | $263,000 | – | 6,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |